NIFTY 50▼23,910.00
-85.35 (-0.36%)
SENSEX▼78,490.52
-291.72 (-0.37%)
NIFTY BANK▼51,091.45
-123.80 (-0.24%)
TATA MOTORS▲828.00
3.90 (0.47%)
SUZLON ENERGY▲66.68
0.36 (0.54%)
TATA STEEL▲150.52
3.57 (2.43%)
INDIAN RAILWAY FINANCE CORP▼149.90
-3.34 (-2.18%)
TATA POWER▲429.30
0.25 (0.06%)
RAIL VIKAS NIGAM▲447.05
0.85 (0.19%)
RELIANCE INDUSTRIES▼1,292.00
-10.15 (-0.78%)
VODAFONE IDEA▲8.07
0.19 (2.41%)
ZOMATO▼240.96
-4.12 (-1.68%)
RELIANCE POWER▼41.95
-0.08 (-0.19%)
INDIAN RENEWABLE ENERGY▼204.14
-1.24 (-0.60%)
ADANI POWER▲586.85
1.85 (0.32%)
YES BANK▲20.41
0.08 (0.39%)
STATE BANK OF INDIA▲832.00
2.15 (0.26%)
NHPC▼80.07
-3.23 (-3.88%)
HDFC BANK▼1,712.85
-1.25 (-0.07%)
OLA ELECTRIC MOBILITY LTD▼75.07
-5.77 (-7.14%)
JIO FIN SERVICES LTD▲320.35
0.50 (0.16%)
INDIAN OIL CORP▼138.39
-0.54 (-0.39%)
BHARAT ELECTRONICS▼279.00
-5.15 (-1.81%)
GTL INFRA▲2.17
0.06 (2.84%)
MRF▼1,18,370.70
-2506.05 (-2.07%)
ADANI PORT & SEZ▼1,306.35
-42.90 (-3.18%)
JAIPRAKASH POWER VENTURES▼17.79
-0.09 (-0.50%)
ITC▼478.35
-6.25 (-1.29%)
Suven Pharmaceuticals Share Price
SUVENPHAR
₹1,334.95+₹14.35 (1.09%) TodayLast updated on 05 Nov, 2024 | 12:44 IST
Suven Pharmaceuticals Share Price Chart
Please wait...
About Suven Pharmaceuticals
Suven Pharmaceuticals Financials
Market cap ₹33,435 Crs | Open ₹1,326.00 | Close ₹1,320.60 |
Circuit range ₹1,584.70 - ₹1,056.50 | Day range ₹1,313.80 - ₹1,353.95 | Year range ₹542.10 - ₹1,353.95 |
Volume 3,99,815 | Avg. traded ₹1,334.64 | Revenue (12m) ₹934 Crs |
Suven PharmaceuticalsSuven Pharmaceuticals Limited is an India-based company. The Company is engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Specialty Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology, and chemical companies. The Company operates through Manufacturing segment. Its geographical segments include India, the United States, Europe, and Rest of the world. In India, the Company sells bulk drugs and intermediates, fine chemicals & services. In the United States, the Company sells intermediates and services. In Europe, the Company sells bulk drugs and intermediates. In other countries, the Company sells bulk drugs, intermediates, and services. The Company’s subsidiaries are Suven Pharma Inc. and Casper Pharma Private Limited.
Suven Pharmaceuticals Key indicators
52 week high ₹1,353.95 | 52 week low ₹542.10 | P/E ratio 138.89 |
P/B ratio 15.42 | ROE 16.03% | ROCE 21.27% |
Dividend yield -- | Debt/Equity ratio 0.02 | EPS 11.97 |
Learn more
Featured in
Investment checklist: (5/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Analyst ratings:
Analyst ratings:
100%
Hold
0%
Sell
0%
This analysis is based on the reviews of 1 experts in the last 7 days
Suven Pharmaceuticals Fundamentals
Suven Pharmaceuticals Financial Ratios
Operating profit margin45.37% | Net profit margin29.74% |
ROE16.03% | ROA13.73% |
ROCE21.27% |
Learn more
Suven Pharmaceuticals Share Price history
Day | Open | Close | Change % |
---|---|---|---|
Mon, Nov 4 2024 | ₹1,334.10 | ₹1,320.60 | -0.49% |
Fri, Nov 1 2024 | ₹1,309.00 | ₹1,327.15 | |
Thu, Oct 31 2024 | ₹1,281.85 | ₹1,313.40 | |
Wed, Oct 30 2024 | ₹1,279.50 | ₹1,277.75 | -0.10% |
Tue, Oct 29 2024 | ₹1,266.90 | ₹1,279.00 | |
Mon, Oct 28 2024 | ₹1,262.40 | ₹1,266.90 | |
Fri, Oct 25 2024 | ₹1,260.85 | ₹1,249.90 | -1.10% |
Thu, Oct 24 2024 | ₹1,250.00 | ₹1,263.85 |
Events
Corporate actions
Dividend • ₹1/share
Ex date 09 Sep 2022
Dividend • ₹5/share
Ex date 09 Sep 2022
Dividend • ₹1/share
Ex date 13 May 2022
Dividend • ₹1/share
Ex date 13 May 2022
Dividend • ₹1/share
Ex date 15 Feb 2022
Dividend • ₹2/share
Ex date 15 Feb 2022
Learn more
More